Results 191 to 200 of about 50,217 (224)

Prevalence of Thyroid Dysfunction in Patients With Chronic Spontaneous Urticaria Attending a Tertiary Care Urticaria Clinic: A Cross-Sectional Study. [PDF]

Cureus
Srinivasan V, Kannan R, Vadivelu S.
europepmc   +1 more source

Patch Testing Is Useful in Patients With Lamotrigine‐Induced Cutaneous Adverse Drug Reactions

Contact Dermatitis, Volume 95, Issue 5, Page 519-522, November 2026.
E. Bertazzo, N. Laviec, C. Toussaint, P. Sanchez‐Pena, B. Milpied   +4 more
wiley   +1 more source

Cellular Responses to Tartrazine and Sulfanilic Acid Exposure in BEAS‐2B Cells: Viability, Apoptosis, and DNA Damage

Journal of Applied Toxicology, Volume 46, Issue 10, Page 3446-3454, October 2026.
ABSTRACT Tartrazine is a synthetic azo dye widely used in food, pharmaceutical, and cosmetic products, resulting in extensive human exposure, while its toxicity and that of its primary metabolite, sulfanilic acid, remain controversial. Considering the reported association of tartrazine with hypersensitivity and allergic‐like reactions, human bronchial ...
Merve Baysal, Abdullah Burak Karaduman, Büşra Korkut Çelikateş, Merve Güven, Özlem Atlı‐Eklioğlu, Sinem Ilgın   +5 more
wiley   +1 more source

Chronic Spontaneous Urticaria in the Era of Targeted Therapy: From Pathogenic Mechanisms to Precision Medicine. [PDF]

Pharmaceutics
Andrzejczak K, Witkowski W, Górka-Dynysiewicz J, Pawłowicz R, Kopeć A.   +4 more
europepmc   +1 more source

A Retrospective Review of 1821 Cases of Eosinophilia in a Single‐Center Study in Eastern China

eJHaem, Volume 7, Issue 5, October 2026.
ABSTRACT Objective: Our study aims to explore the types of diseases that may cause eosinophilia and the changes in the disease spectrum of different degrees of eosinophilia. Methods We retrospectively analyzed patients who were admitted to the First Affiliated Hospital of Soochow University from July 1, 2023 to June 30, 2024, and had at least twice ...
Yanan Ma, Linlin Wang, Yuexin Cheng, Xiaofei Yang, Suning Chen   +4 more
wiley   +1 more source

Impact of Chronic Spontaneous Urticaria on Major Life-Changing Decisions: An Exploratory Cross-Sectional Study. [PDF]

J Clin Med
Fuentes-Barragán L, León-Pérez FJ, Sanabria-de la Torre R, García-Moronta C, Molina-Leyva A, Arias-Santiago S, Montero-Vílchez T.   +6 more
europepmc   +1 more source

Graft‐Versus‐Tumour Effect Following Allogeneic Haematopoietic Stem Cell Transplantation in a Paediatric Patient With Mogamulizumab‐Treated Primary Cutaneous Peripheral T‐Cell Lymphoma

eJHaem, Volume 7, Issue 5, October 2026.
ABSTRACT Introduction Primary cutaneous peripheral T‐cell lymphoma, not otherwise specified (pcPTCL‐NOS), is exceptionally rare in children, and evidence guiding diagnosis and treatment is limited. Case Presentation A 10‐year‐old boy with pcPTCL‐NOS refractory to chemotherapy received mogamulizumab prior to allogeneic haematopoietic stem cell ...
Maria Ebbesen Sørum, Tania Masmas, Hilde Uhlving, Lene D. Sjö, Signe Modvig, Hanne V. Marquart, Lone Skov, Lisa Hjalgrim, Marianne Ifversen, Peter Pontoppidan   +9 more
wiley   +1 more source

Omalizumab-Associated Post-Injection Urticaria Exacerbation and Urticaria-Related Adverse Reactions During Treatment for Chronic Urticaria: A Scoping Review. [PDF]

Life (Basel)
Tawanwongsri W, Jaruvijitrattana P, Eden C.   +2 more
europepmc   +1 more source

Integrative Multiomics Profiling Reveals Immune Determinants of Response to Disitamab Vedotin Plus Penpulimab in HER2‐Low Breast Cancer

MedComm, Volume 7, Issue 10, October 2026.
This prospective single‐arm study evaluated neoadjuvant disitamab vedotin plus penpulimab in 20 patients with Stage II–III HER2‐low breast cancer. The regimen showed preliminary activity (pCR 20.0% intention‐to‐treat, 25.0% evaluable; ORR 56.3%) with manageable toxicity.
Xiaoxiao Liu, Yuting Song, Lei Liu, Aaron Qi Zhang, Xin Xie, Bing Wei, Ping He, Chunying Zhuang, Juanjuan Li, Xi Yan, Tinglun Tian, Xiaorong Zhong, Jie Chen, Yan Cheng, Dan Zheng, Shibao Li, Hao Wang, Ting Luo   +17 more
wiley   +1 more source

Therapeutic Potential of Isoniazid in Inflammatory Skin Diseases: A Review. [PDF]

Clin Cosmet Investig Dermatol
Zhang S, Tang Y, Wen J, Song J, Gong W, Chen T.   +5 more
europepmc   +1 more source